Amgen (AMGN) Cash from Investing Activities Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
-16.79% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-250.17% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
21.90% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-586.62% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-60.18% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
526.51% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-76.02% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
73.75% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-60.18% |
| Dec 31, 2025 |
-72.39% |
| Sep 30, 2025 |
-97.14% |
| Jun 30, 2025 |
-79.26% |
| Mar 31, 2025 |
-105.99% |
| Dec 31, 2024 |
98.52% |
| Sep 30, 2024 |
19.85% |
| Jun 30, 2024 |
-2.84% |
| Mar 31, 2024 |
-115.98% |
| Dec 31, 2023 |
-679.99% |
| Sep 30, 2023 |
1.87% |
| Jun 30, 2023 |
90.38% |
| Mar 31, 2023 |
1,323.42% |
| Dec 31, 2022 |
-1,410.00% |
| Sep 30, 2022 |
-465.75% |
| Jun 30, 2022 |
-281.39% |
| Mar 31, 2022 |
65.20% |
| Dec 31, 2021 |
83.38% |
| Sep 30, 2021 |
104.48% |
| Jun 30, 2021 |
156.00% |
| Mar 31, 2021 |
-38.70% |
| Dec 31, 2020 |
76.79% |
| Sep 30, 2020 |
-130.31% |
| Jun 30, 2020 |
-178.65% |
| Mar 31, 2020 |
-106.47% |
| Dec 31, 2019 |
-28.60% |
| Sep 30, 2019 |
374.56% |
| Jun 30, 2019 |
-6.57% |
| Mar 31, 2019 |
-76.15% |
| Dec 31, 2018 |
-5,844.87% |
| Sep 30, 2018 |
157.29% |
| Jun 30, 2018 |
262.05% |
| Mar 31, 2018 |
9,594.27% |
| Dec 31, 2017 |
93.62% |
| Sep 30, 2017 |
17.29% |
| Jun 30, 2017 |
-175.95% |
| Mar 31, 2017 |
96.42% |
| Dec 31, 2016 |
-424.46% |
| Sep 30, 2016 |
-19.27% |
| Jun 30, 2016 |
72.15% |
| Mar 31, 2016 |
-361.13% |
| Dec 31, 2015 |
-162.30% |
| Sep 30, 2015 |
31.00% |
| Jun 30, 2015 |
4.03% |
| Mar 31, 2015 |
-24.44% |
| Dec 31, 2014 |
103.70% |
| Sep 30, 2014 |
-37.00% |
| Jun 30, 2014 |
-225.47% |
| Mar 31, 2014 |
-142.29% |
| Dec 31, 2013 |
-398.18% |
| Sep 30, 2013 |
33.22% |
| Jun 30, 2013 |
180.29% |
| Mar 31, 2013 |
177.11% |
| Dec 31, 2012 |
-823.18% |
| Sep 30, 2012 |
-270.25% |
| Jun 30, 2012 |
-388.42% |
| Mar 31, 2012 |
-322.70% |
| Dec 31, 2011 |
55.19% |
| Sep 30, 2011 |
32.57% |
| Jun 30, 2011 |
158.95% |
| Mar 31, 2011 |
41.88% |
| Dec 31, 2010 |
-44.84% |
| Sep 30, 2010 |
10.56% |
| Jun 30, 2010 |
9.23% |
| Mar 31, 2010 |
-787.05% |
